Ermeza
Product Images NDC 49502-378

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ermeza (NDC 49502-378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levothyroxine Sodium Structural Formula (Image 01)

Levothyroxine Sodium Structural Formula (Image 01)
Chemical structure of ERMEZA active ingredient as shown in the molecular diagram, depicting the arrangement of atoms including iodine substitutions, sodium carboxylate group, and an amino group.*
FDA Label Image

Mcg Dosage To mL Conversion (Image 02)

Mcg Dosage To mL Conversion (Image 02)
A text panel showing a dosage conversion formula with "Dosage (mcg)" equal to "Dosage (mL)" divided by 30.*
FDA Label Image

Instructions For Use Figure A (Image 03)

Instructions For Use Figure A (Image 03)
An instructional diagram showing two oral syringes used with ERMEZA: a 5 mL syringe and a 10 mL syringe. The diagram labels the syringe plunger, syringe barrel, and highlights example graduation marks at 4 mL on the 5 mL syringe and 8 mL on the 10 mL syringe for measuring prescribed doses.*
FDA Label Image

Instructions For Use Figure B (Image 04)

Instructions For Use Figure B (Image 04)
An instructional diagram showing how to measure a 3.7 mL dose using a vertical measuring device with graduated markings. The close-up inset highlights the 3.7 mL mark to indicate the correct dosing level.*
FDA Label Image

Instructions For Use Figure C (Image 05)

Instructions For Use Figure C (Image 05)
An instructional illustration showing a person receiving an oral liquid medication administered via an oral syringe. The syringe is positioned at the person's mouth, indicating correct administration technique.*
FDA Label Image

Instructions For Use Figure D (Image 06)

Instructions For Use Figure D (Image 06)
An instructional illustration showing hands assembling a syringe. One hand holds the syringe barrel, and the other inserts the plunger, indicated by a directional arrow. The image serves as a step in preparing the syringe for use, associated with the ERMEZA product by Viatris Specialty LLC.*
FDA Label Image

Mcg Dosage To mL Conversion (Image 07)

Mcg Dosage To mL Conversion (Image 07)
A text panel showing a dosage calculation formula: Dosage in micrograms (mcg) divided by 30 equals Dosage in milliliters (mL). The equation is formatted with 30 as the denominator and Dosage (mcg) as the numerator.*
FDA Label Image

Ermeza Oral Solution 150 Mcg/5 mL Carton Label (Image 08)

Ermeza Oral Solution 150 Mcg/5 mL Carton Label (Image 08)
Packaging label for Ermeza (levothyroxine sodium) oral solution, 150 mcg/5 mL (30 mcg/mL), in a 75 mL oral solution. The label includes dosage strength, administration route, storage instructions, and manufacturing information. Labeler is Viatris Specialty LLC under the Mylan brand. The label also features barcodes, lot, expiration placeholders, and directions to read the instructions before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.